Patrick H.C. van Berkel

Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange

Aran F. Labrijn, Joyce Meesters, Bart E.C.G. de Goeij et al. · Proceedings of the National Academy of Sciences · 2013 · 330 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +17

Large scale production of recombinant human lactoferrin in the milk of transgenic cows

Patrick H.C. van Berkel, Mick M. Welling, Marlieke Geerts et al. · Nature Biotechnology · 2002 · 292 citations

Agriculture, Biotechnology, Dairy Science +16

Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage

Tanja Schneider‐Merck, Jeroen J. Lammerts van Bueren, Sven Berger et al. · The Journal of Immunology · 2009 · 219 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells

Matthias Peipp, Jeroen J. Lammerts van Bueren, Tanja Schneider‐Merck et al. · Blood · 2008 · 218 citations · Full text

Pharmacy, Cell Biology, Immunology +17

N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA

Patrick H.C. van Berkel, E. J. Marlieke GEERTS, A. Harry VAN VEEN et al. · Biochemical Journal · 1997 · 207 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16